Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Inozyme Pharma, Inc. (INZY) had Free Cash Flow per Share of $-0.45 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-28.04M |
|
-- |
|
-- |
|
$27.69M |
|
$-27.69M |
|
$-0.35M |
|
$-28.04M |
|
$-28.04M |
|
$-28.04M |
|
$-28.04M |
|
$-28.04M |
|
$-28.04M |
|
$-27.69M |
|
$-28.20M |
|
64.28M |
|
64.28M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$93.64M |
|
$0.61M |
|
$1.53M |
|
$95.16M |
|
$42.78M |
|
$20.59M |
|
$20.59M |
|
$63.37M |
|
$31.80M |
|
$31.80M |
|
$31.80M |
|
64.47M |
|
| Cash Flow Statement Financials | |
$-29.15M |
|
$33.68M |
|
$0.23M |
|
$21.39M |
|
$26.16M |
|
$4.76M |
|
$1.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.19 |
|
-- |
|
-- |
|
0.39 |
|
1.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-29.15M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-88.18% |
|
-88.18% |
|
-29.46% |
|
-53.53% |
|
$0.49 |
|
|
Free Cash Flow per Share |
$-0.45 |
$-0.45 |
|